Ares Genetics secures funding to advance AI-powered infectious disease and antibiotic resistance test
Curetis’ wholly-owned subsidiary Ares Genetics has secured funding from the Vienna Business Agency for the development of a…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Jan 19
Curetis’ wholly-owned subsidiary Ares Genetics has secured funding from the Vienna Business Agency for the development of a…
09 Jan 19
Molecular technology firm ArcherDX has secured breakthrough device designation from the US Food and Drug Administration (FDA) for…
07 Jan 19
Clinical genomics informatics company PierianDx has signed a multi-year agreement with Illumina to support cancer research and diagnostics.
07 Jan 19
Paragon Genomics has partnered with MGI Tech (MGI), a subsidiary of BGI Group, on the distribution of its…
04 Jan 19
Veracyte has entered into a long-term strategic collaboration with Johnson & Johnson Innovation and the Lung Cancer Initiative…
21 Dec 18
Oncimmune has entered into an agreement with America’s Choice Provider Network (ACPN) to expand access to its simple…
20 Dec 18
Researchers led by University of Queensland are all set to begin safety testing of ultrasound technique that could…
17 Dec 18
Biotech company Earth Science Tech (ETST) has stated that the pre-launch testing of its Hygee medical device showed…
17 Dec 18
Precision oncology firm Guardant Health has entered into a multi-year agreement with AstraZeneca to develop companion diagnostic (CDx)…
14 Dec 18
Francis Medical, a company engaged in the development of developing urological cancer treatments, has raised $18m Series A…